Back to Search
ALLEN MELEMED, MD
MD
Pediatric Hematology & Oncology Physician
NPI: 1487747374Individual
Specialties, Licenses & Credentials
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
01041805(IN)
Research & Publications (14)
Potential role of hematopoietic stem cell transplantation in children with secondary acute lymphocytic leukemia.
PMID 11850713·Bone Marrow Transplant·2002
5-case
Gemcitabine plus Paclitaxel versus Paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment.
PMID 18711184·J Clin Oncol·2008
3-trial
Phase I/II pharmacokinetic study of pemetrexed and epirubicin in patients with locally advanced or metastatic breast cancer.
PMID 18269776·Clin Breast Cancer·2007
3-trial
Phase III double-blind trial of arzoxifene compared with tamoxifen for locally advanced or metastatic breast cancer.
PMID 17971595·J Clin Oncol·2007
3-trial
A randomized, double-blind, phase II study of two doses of pemetrexed as first-line chemotherapy for advanced breast cancer.
PMID 17575230·Clin Cancer Res·2007
3-trial
Phase I trial and pharmacokinetic study of pemetrexed in children with refractory solid tumors: the Children's Oncology Group.
PMID 17442992·J Clin Oncol·2007
3-trial
A phase I study of pemetrexed (ALIMTA) and cyclophosphamide in patients with locally advanced or metastatic breast cancer.
PMID 17145830·Clin Cancer Res·2006
3-trial
Comprehensive review of chemotherapy in patients with metastatic breast cancer.
PMID 16258122·J Clin Oncol·2005
8-other
Phase II study of pemetrexed in patients pretreated with an anthracycline, a taxane, and capecitabine for advanced breast cancer.
PMID 16001992·Clin Breast Cancer·2005
3-trial
A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma.
PMID 15661224·Gynecol Oncol·2005
3-trial
A phase II trial of arzoxifene, a selective estrogen response modulator, in patients with recurrent or advanced endometrial cancer.
PMID 12821343·Gynecol Oncol·2003
3-trial
Phase II, randomized, double-blind study of two dose levels of arzoxifene in patients with locally advanced or metastatic breast cancer.
PMID 12637464·J Clin Oncol·2003
3-trial
Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trial.
PMID 11810037·Oncology·2002
3-trial
Phase I study of a third-generation selective estrogen receptor modulator, LY353381.HCL, in metastatic breast cancer.
PMID 11283133·J Clin Oncol·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 702 BARNHILL DR
INDIANAPOLIS, IN 46202 - Phone
- (317) 274-1201
Quick Facts
- NPI
- 1487747374
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 14
Are you this provider?
Claim Your Profile